# A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

> **NCT00995150** · PHASE3 · TERMINATED · sponsor: **Medicines360** · enrollment: 1910 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** LNG20
- **DRUG:** Mirena

## Key facts

- **NCT ID:** NCT00995150
- **Lead sponsor:** Medicines360
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2021-10-12
- **Final completion:** 2021-10-12
- **Target enrollment:** 1910 (ACTUAL)
- **Why stopped:** The data cutoff date of 05 April 2021 was chosen as it coincides with all subjects completing through Year 8 of use (intended duration of use for the product).
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995150, "A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00995150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*